Category Archives: Cell Biology

Global Integrated Digital Microscopy Market Study, 2020 – Exploring Disruptive Innovations and Applications in Live Cell Imaging, Time-Lapse Imaging…

Dublin, April 02, 2020 (GLOBE NEWSWIRE) -- The "Technology Innovations and Emerging Applications of Integrated Digital Microscopy" report has been added to ResearchAndMarkets.com's offering.

This research service (RS) is a study on the technology innovations and emerging applications of integrated digital microscopy. The RS will also focus on the drivers and challenges in the digital microscopy industry. Emerging growth opportunities and IP activity in the area of the integrated digital microscopy have also been discussed.

An integrated digital microscope, in contrast to the traditional optical microscope, displays the image output directly on a monitor instead of an eyepiece. Thus, the sample can be viewed instantly and easily on a desktop, with the user in a comfortable position. The data can also be analyzed and shared with others with ease. This enables rapid imaging and analysis of live cells in an incubator environment or a closed laminar flow cabinet for long durations, as well as high content imaging.

Available in desktop, incubator-compatible, handheld, and wireless pocket-friendly formats, the integrated digital microscopy industry is driven by the technology advancements of the microscope components, improvements in the capabilities of digital camera, demand for ergonomics and ease in data transfer, and emerging advanced life science applications, which require digital microscopes.

Key Topics Covered

1. Executive Summary1.1 Scope of Research1.2 Research Methodology1.3 Publisher Perspective - Automation of Digital Microscopes Improves Reproducibility in Live Cell and High Content Imaging

2. Technology Snapshot2.1 Digital Microscopes - Introduction, Advantages, and Limitations2.2 Applications of Digital Microscopy in Life Science2.2.1 Live Cell Imaging for Understanding Cell Biology and Mechanism of Diseases2.2.2 High Content Imaging for Drug Discovery and Development2.2.3 Slide Scanners for Digital Imaging of Pathology Slides2.2.4 Phase Contrast Microscopy is the Most Commonly Used Modality for Label-free Imaging2.2.5 Time-lapse Imaging is Useful in Studies on Cellular Dynamics and Migration2.2.6 Digital Microscope for Surgery, Microfluidics, Forensic Science, Entomology, Botany, and Zoology2.3 Definitions of Different Imaging Capabilities of Integrated Digital Microscope2.4 Key End-user Requirements in Integrated Digital Microscope2.5 Integrated Digital Microscopes Can Be Categorized Based On The Mode of Usage2.5.1 Key Market Participants in the Desktop Digital Microscope Segment2.5.2 Key Market Participants in the Incubator-compatible Digital Microscope Segment - Integrated Incubator2.5.3 Key Market Participants in the Incubator-compatible Digital Microscope Segment - Instrument Kept Inside Incubator2.5.4 Key Market Participants in the Incubator-compatible Digital Microscope Segment - Optional Incubator Attachment2.5.5 Key Market Participants in the Handheld and Pocket Digital Microscope Segment

3. Integrated Digital Microscope - Industry Overview and Trends Assessment3.1 Rising Demand for Ergonomics and Emerging Life Science Applications Drive the Integrated Digital Microscope Industry3.2 Resistance to Change and Lack of Flexibility Affect the Integrated Digital Microscope Industry3.3 Integrated Digital Microscope Provides Vast Biologically Relevant Information on Cell Biology3.4 Proper Calibration of Integrated Digital Microscope is Essential for Quality Images3.5 Impact of Key Market Drivers and Challenges on the Integrated Digital Microscope Industry3.6 Status of the Key End-user Requirements in Integrated Digital Microscope3.7 Adoption of Automation Technologies is High Worldwide

4. Technology Profiles4.1 Technology Segment - Desktop Digital Microscope4.1.1 Standalone Digital Microscope for Use Inside a Closed Laminar Flow Cabinet4.1.2 Rapid Imaging Integrated Digital Microscope for Digital Pathology Application4.2 Technology Segment - Incubator-compatible Digital Microscope4.2.1 Live Cell Plate Reader with Real-time Image Cytometry and Cell Incubation Capabilities4.2.2 Real-time Automated Live Cell Analysis System Inside an Incubator4.2.3 Laser-based, Automated Imaging and Analysis Platform for High Content Screening4.3 Technology Segment - Handheld Digital Microscope4.3.1 Handheld Wireless Digital Microscope with Flexible LED Control and Automatic Magnification Reading4.4 Technology Segment - Pocket Microscope4.4.1 Portable Smartphone Microscope for Educational Purpose

5. Growth Opportunities in the Integrated Digital Microscope Industry5.1 Need of Digital Microscopes with Capabilities for Life Science Experiments in APAC Region5.2 Including Flexibility Will Improve Adoption of Integrated Digital Microscopes5.3 Live Cell Imaging and High Content Screening Innovators are the Key Stakeholders in the Integrated Digital Microscope Industry5.4 Key Conclusions and Strategic Recommendations

6. Intellectual Property Landscape of Integrated Digital Microscope in Life Science Segment6.1 IP Activity Indicates the Growing Interest in Integrated Digital Microscopy for Cell Imaging6.2 Key Patents to Check

7. Key Industry Participants7.1 Database of Key Industry Participants

Story continues

For more information about this report visit https://www.researchandmarkets.com/r/w0w1qi

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Visit link:
Global Integrated Digital Microscopy Market Study, 2020 - Exploring Disruptive Innovations and Applications in Live Cell Imaging, Time-Lapse Imaging...

Study finds evolutionary adaptation helped cave bears hibernate, but also may have caused their extinction – UB Now: News and views for UB faculty and…

A study published in Science Advances on April 1 reveals a new hypothesis that may explain why European cave bears went extinct during past climate change periods. The research was motivated by controversy in the scientific literature as to what the animal (Ursus spelaeus) ate and how that affected its demise.

The new hypothesis emerged, in part, from computational analysis and computer biting simulations conducted in the laboratory of Jack Tseng, assistant professor of pathology and anatomical sciences in the Jacobs School of Medicine and Biomedical Sciences at UB.

Tseng is a co-author on the paper with corresponding authors Borja Figueirido and Alejandro Prez-Ramos, his doctoral student and first author, both of the Departamento de Ecologia y Geologia of the Universidad de Malaga, Spain.

Cave bears were a species of bear (Ursus spelaeus) that lived in Europe and Asia and went extinct about 24,000 years ago. According to Figueirido, researchers have proposed different diets for cave bears, ranging from pure herbivory to carnivory or even scavenging.

Knowing the feeding behaviour of the cave bear is not a trivial aspect, he says. Feeding behavior is intimately related to its decline and extinction.

He noted that two main hypotheses, not necessarily exclusive, have been proposed to explain cave bear extinction: a human-driven decline, either by competition for resources or by direct hunting, or a substantial demise in population sizes as a result of the climatic cooling that occurred during the late Pleistocene, which caused vegetation to wane.

Previous research shows that cave bears were primarily herbivorous, at least from 100,000 to 20,000 years ago. But even during the cooling periods when vegetation productivity waned, these bears didnt change their diets. The researchers propose that this dietary inflexibility, combined with competition for cave shelters by humans, is what led to their extinction.

To find out if there were biomechanical explanations behind their inflexible diets meaning that the bears werent physically capable of adjusting their diets effectively during times of limited vegetation resources the researchers analyzed three-dimensional computer simulations of different feeding scenarios.

They were especially interested in the sinuses of the bears because large paranasal sinuses allow for greater metabolic control, critical to survival during hibernation.

Our study proposes that climate cooling probably forced the selection of highly developed sinuses, which in turn led to the appearance of the characteristic domed skull of the cave bear lineage, says Prez-Ramos.

Tseng explains that when the sinus system expands, the act of chewing may cause more or less strain on the skull. In both humans and bears, the sinus system lightens the weight of the face, reducing the amount of bone tissue needed to grow the skull.

Mechanically speaking, being thickheaded may not be a bad thing because more bone means more structural strength, he says. However, our findings support the interpretation that requirements for sinus system function in cave bears necessitated a trade-off between sinus development and skull strength.

Tseng and Prez-Ramos, who spent three months at UB to learn the procedure, used a biomechanical simulation methodology to estimate the biting stresses and strains in different bear species and different models of them. The bear skull specimens used were from several European institutions, where CT scans had been done on them, as well as the scientific CT repository, also known as the digital morphology library, at the University of Texas at Austin.

They found that the development of paranasal sinuses in cave bears caused the cranial dome to expand upward and backward from the forehead, changing the geometry of the bears skull.

This geometrical change generated a mechanically suboptimal cranial shape, with a very low efficiency to dissipate the stress along the skull, particularly when biting with the canines or carnassials, the teeth most often used by predatory mammals, says Prez-Ramos.

When the sinus system expands, Tseng explains, it results in bone reduction relative to the size of the skull, and therefore less structural support to resist the physical forces that chewing generates. Although other mammals with expanded sinuses, such as hyenas, appear to have evolutionarily modified their skull shape to effectively deal with decreased structural support, cave bear skulls showed compromised biomechanical capability compared to living bear species.

Through the use of new techniques and virtual methods, such as biomechanical simulations across each tooth and the comparative internal anatomical study of the paranasal sinuses, we propose that large sinuses were probably selected in cave bears in order to be able to hibernate for longer periods with very low metabolic costs, says Prez-Ramos.

Ultimately, though, that trade-off may have resulted in the extinction of the species, a finding that also has relevance to humans, Tseng adds.

Being able to stay alive during the coldest periods would have been equally important to human and bear alike, he says. The success or demise of prehistoric megafauna, such as cave bears, provide crucial clues as to how humans may have out-competed and out-survived other large mammals during a critical time for the evolution of our own species.

Funding for this project was provided by theSpanish Ministryof Economy and Competitivenessgrants CGL2012-37866,CGL2015-68300P andBES-2013-065469. The Computational Cell Biology, Anatomy, and Pathology GraduateProgram in the Jacobs School provided logistical support for Alejandro Prez-Ramos residence in Tsengs laboratory.

View original post here:
Study finds evolutionary adaptation helped cave bears hibernate, but also may have caused their extinction - UB Now: News and views for UB faculty and...

Life Science Tools and Reagents Market Size Growth Forecast 2020 to 2025 – Express Journal

Growth Analysis Report onLife Science Tools and Reagents Market size | Industry Segment by Applications (Proteomics, Cell biology research, Epigenetics, Metabolomics, Bioinformatics and Others), by Type (Tools and Reagents), Regional Outlook, Market Demand, Latest Trends, Life Science Tools and Reagents Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025.Analyzes current market size and upcoming 5 years growth of this industry.

The recent study on Life Science Tools and Reagents market Analysis report provides information about this industry with regards to thorough assessment of this business. The Life Science Tools and Reagents market size is appropriately divided into pivotal segments according to the report. A synopsis of the industry with regards to market size concerning renumeration and volume aspects along with the current Life Science Tools and Reagents market shares scenario is offered in the report.

The study on Life Science Tools and Reagents Market offers information related to the geographical landscape of this vertical along with the forms that have achieved profitable position across the marketplace.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/28985

An outline of the Life Science Tools and Reagents market scope

Synopsis of Life Science Tools and Reagents Market competitive landscape

Life Science Tools and Reagents Market Analysis of the regional expanse

Summary of the Life Science Tools and Reagents market segmentation

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/28985

Originally posted here:
Life Science Tools and Reagents Market Size Growth Forecast 2020 to 2025 - Express Journal

Unlocking the Secrets of Brown Fat – Technology Networks

In recent years, brown fat has garnered attention as the so-called good fat that can protect against obesity and its associated health risks, like cardiovascular disease and diabetes. Two separate major studies, one led by Liangyou Rui, Ph.D. and one by Ling Qi, Ph.D., both with the department of molecular & integrative physiology, help explain brown fats properties.Brown fat and the brainLocated in small pockets throughout the body, most mammals use brown fat (and its closely related cousin beige fat) to stay warm. In mice and humans, if you have more brown or beige fat, you are more protected from metabolic disease, says Rui, the Louis G. D'Alecy Collegiate Professor of physiology at U-M Medical School, whose lab studies the molecular and physiological mechanisms of obesity, diabetes and fatty liver disease. In a new study, Rui, first author Lin Jiang, Ph.D., and their colleagues reveal a pathway by which the hormone leptin contributes to weight loss.

Leptin regulates body weight by controlling appetite and energy expenditure, but exactly how has been a mystery. What is known, says Rui, is that leptin activates brown and beige fat. The new study elucidates a molecular accelerator of leptin action in the brain called Sh2b1. His team has found that Sh2b1 in the hypothalamus, an important brain region controlling body temperature and hunger among other functions, promotes the stimulation of the sympathetic nervous system. The sympathetic nervous system sends signals to brown and beige fat to activate it, thus maintaining body weight and metabolism.

The team demonstrated this proof-of-principle by creating two mouse models. Mice that lacked the Sh2b1 gene in the leptin receptor neurons had an incredibly reduced sympathetic drive to the brown and beige fat and reduced capability to promote energy expenditure, says Rui. This reduced the ability of brown fat to be metabolized into heat, lowering the mices core body temperature. Whats more, the mice also developed obesity, insulin resistance and a fatty liver. In contrast, mice with extra expression of Sh2b1 in their brains were protected from obesity.

No one knew that Sh2b1 in the brain controls the sympathetic nervous system or was required for leptin to activate brown fat to increase energy expenditure, notes Rui. As for how this finding could be applied to humans, he says the hope is to eventually find a way to increase expression of Sh2b1 or its ability to enhance leptin signaling and fat burning.Brown fat and the cellBrown fat gets its color from high amounts of iron-containing mitochondria, unlike the standard white fat linked to obesity. A team led by Qi, a professor of molecular & integrative physiology and internal medicine at U-M Medical School has been studying how mitochondria, the power plant of the cell, and another cellular structure called the endoplasmic reticulum (ER), which is involved in the production of proteins and lipids, interact inside brown fat cells.

In particular, theyve studied the role of a protein complex involved in a process called ER-associated protein degradation, or ERAD. Simply put, ERAD is the process of removing and destroying misfolded proteins, like taking out the trash out of the ER.

Everyone thought that ERAD was just part of the general cellular response when cells are undergoing ER stress, says Qi. Weve shown over the past six years that it plays a fundamental role in health and disease.

In a new study, Qi along with first authors Zhangsen Zhou, Ph.D., Mauricio Torres, Ph.D., and their colleagues demonstrate how an ERAD protein complex affects the proper function of mitochondria.

Typically, the ER and mitochondria have ongoing interaction at touch points called mitochondria-associated membranes. These points of contact mark areas for mitochondria to divide for the production of new mitochondria and for the exchange of other molecules such as lipids and calcium. The ER forms tubules that surround the mitochondria to get them ready for division.

Using state of the art 3D imaging, the researchers discovered what happens to mitochondria in brown fat that are missing part of an ERAD protein complex, called Sel1L-Hrd1, when exposed to cold.

When you delete this complex in brown adipocytes, the mitochondria become elongated and enlarged, says Qi. The 3D image enabled them to view a previously unrecognized interaction between the mitochondria and the ER, with the mitochondria wrapping in a U-shape around the ER tubules.

When the mice were placed in a cold environment, the ends of the outer membrane of the mitochondria folded back on itself, eventually fusing and completely enveloping the ER tubules. The result, says Qi, are abnormally large, misshapen, dysfunctional mitochondria.

We showed that these mitochondria dont function normally and the mice become cold sensitive, their body temperature dropping very quickly, says Qi. In other words, without this ERAD protein complex, the brown fat is not being used to generate heat. Under a microscope, this dysfunctional brown fat had larger droplets of lipids than brown fat from mice with the protein complex intact.

This is highly unexpected. The results here fundamentally change our understanding of ER-mitochondrial communication and further demonstrate the importance of an ER degradation complex in cell biology.ReferencesZhou et al. (2020) Endoplasmic reticulumassociated degradation regulates mitochondrial dynamics in brown adipocytes. Science. DOI: https://doi.org/10.1126/science.aay2494

Jiang et al. (2020) Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease. Nature Communications. DOI: https://doi.org/10.1038/s41467-020-15328-3

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Follow this link:
Unlocking the Secrets of Brown Fat - Technology Networks

Bruker Highlights New Analytical Systems and Applied Market Solutions – Yahoo Finance

Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed or cancelled due to COVID-19, Bruker remains committed to the success of its customers, and is proceeding with on-line launches at this time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200401005060/en/

Omega 5 FTIR Gas Analyzer (Photo: Business Wire)

OMEGA 5 FTIR Gas Analyzer: OMEGA 5 is a new Fourier Transform Infrared (FTIR) gas analyzer that is rackmounted and equipped with a multi-reflection gas cell of 5 m optical path length. It allows automated, precision and real-time monitoring of gas concentrations even in mixtures. The OMEGA 5 is designed for applications like process monitoring, the investigation of catalytic processes, or the determination of gas impurities. More info

FOURIER CrimeLab Benchtop FT-NMR for Forensic Laboratories: Bruker envisions that interconnected high-field NMR spectrometers at central forensic laboratories and benchtop FOURIER CrimeLab 80 MHz FT-NMRs at local labs will enable law enforcement to unambiguously identify suspicious known or new psychoactive substances. Benchtop FT-NMR is made easy for novices by the new push-button, non-expert software GoScan. Please watch our recorded webinar

S2 PUMA - Benchtop X-Ray Elemental Analyzer: the next-generation benchtop Energy Dispersive X-Ray Fluorescence (EDXRF) spectrometer S2 PUMATM Series 2 is equipped with HighSenseTM technology for increases in throughput by about a factor of 3x. Brukers software SPECTRA.ELEMENTSTM comes with enhanced features and faster algorithms, leading to ~40% shorter evaluation times. The S2 PUMA Series 2 supports elemental analysis applications from cement, steel, mining and petrochemical, to food analysis and pharma QC. The new mapping stage also extends its applications into semiconductors and coatings, where spatial resolution is required. Please watch our recorded webinar

Sierra SPR-24 Pro Biopharma Workhorse: Bruker expands its Surface Plasmon Resonance (SPR) product line with the Sierra SPR-24 Pro, which complements the highest-performance Sierra SPR-32. The new, robust SPR-24 Pro offers high performance and throughput for biopharma applications such as antibody characterization, protein-protein and protein-small molecule interactions, fragment screening, etc. It offers an 8-channel, 3-sensor-spot design (i.e. 24 addressable spots) with automated operation by robotic plate handling for further increases in SPR throughput. Please watch our upcoming webinar

Other on-demand and upcoming webinars on a wide range of applications can be can be found at http://www.bruker.com/webinars

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Brukers high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: http://www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200401005060/en/

Contacts

Investor Contact: Miroslava MinkovaDirector, Investor Relations & Corporate DevelopmentT: +1 (978) 663-3660 x1479E: investor.relations@bruker.com

Media Contact: Dr. Thorsten ThielVP of Group MarketingT: +49 (721) 51616500E: thorsten.thiel@bruker.com

More:
Bruker Highlights New Analytical Systems and Applied Market Solutions - Yahoo Finance

Stem Cell Therapy for Colon Cancer – Yahoo Finance

WASHINGTON, April 2, 2020 /PRNewswire/ -- An article published in Experimental Biology and Medicine (Volume 245, Issue 6, March 2020) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220910690) examines the safety of stem cell therapy for the treatment of colon cancer.The study, led by Dr. J. Liu in the State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design at the East China University of Science and Technology in Shanghai (China), reports that mesenchymal stem cells from a variety of sources promote the growth and metastasis of colon cancer cells in an animal model.

Mesenchymal stem (MSCs), a category of adult stem cells, are being evaluated as therapy for numerous cancers.MSCs are excellent carriers for tumor treatment because they migrate to tumor tissues, can be genetically modified to secrete anticancer molecules and do not elicit immune responses.Clinical trials have shown that MSCs carrying modified genes can be used to treat colon cancer as well as ulcerative colitis. However, some studies have demonstrated MSCs can differentiate into cancer-associated fibroblasts and promote tumor growth.Therefore, additional studies are needed to evaluate the safety of MSCs for targeted treatment of colon cancer.

In the current study, Dr. Liu and colleagues examined the effects of mesenchymal stem cells (MSCs) from three sources (bone marrow, adipose and placenta) on colon cancer cells.MSCs from all three sources promoted tumor growth and metastasis in vivo. In vitro studies demonstrated that MSCs promote colon cancer cell stemness and epithelial to mesenchymal transition, which would enhance tumor growth and metastasis respectively.Finally, the detrimental effects of MSCs could be reversed by blocking IL-8 signaling pathways. Dr. Ma, co-author on the study, said that "Mesenchymal stem cells have a dual role: promoting and/or suppressing cancer. Which effect is dominant depends on the type of tumor cell, the tissue source of the MSC and the interaction between the MSC and the cancer cell. This is the major issue in the clinical application research of MSCs, and additional preclinical experimental data will be needed to evaluate the safety of MSCs for colon cancer treatment."

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology & Medicine, said: "Lui and colleagues have performed elegant studies on the impact of mesenchymal stem cells (MSCs), from various sources, upon the proliferation, stemness and metastasis of colon cancer stem cells (CSCs) in vitro and in vivo. They further demonstrate that IL-8 stimulates the interaction between colon CSCs and MSCs, and activates the MAPK signaling pathway in colon CSCs.This provides a basis for the further study of MSCs as a biologic therapy for colon cancer."

Experimental Biology and Medicine is a global journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership, visit http://www.sebm.org. For anyone interested in publishing in the journal, please visit http://ebm.sagepub.com.

Related Images

logo.png Logo

View original content to download multimedia:http://www.prnewswire.com/news-releases/stem-cell-therapy-for-colon-cancer-301033659.html

SOURCE Experimental Biology and Medicine

Read the original:
Stem Cell Therapy for Colon Cancer - Yahoo Finance

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy…

SAN DIEGO, April 1, 2020 /PRNewswire/ -- Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson disease, today announced the close of its Series A funding round of $70 million. OrbiMed led the investment round with participation from ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and Sam Altman.

"Our mission at Aspen Neuroscience is to develop a restorative, disease modifying autologous neuron therapy for people suffering from Parkinson disease," said Dr. Howard Federoff, Chief Executive Officer of Aspen Neuroscience. "We are dedicated to using a person's own cells for replacement therapy and bringing best-in-class treatments to people suffering from Parkinson disease as rapidly as possible."

"We are impressed by the progress Aspen has made to date against its goals to develop innovative therapies to treat Parkinson disease and encouraged by the broader investment community's support of the company," said Jonathan Silverstein, Managing Partner of OrbiMed.

Aspen's lead product, ANPD001, is currently undergoing investigational new drug (IND)-enabling studies for the treatment of sporadic forms of Parkinson disease. Aspen's second product, ANPD002, combines gene correction and autologous neuron therapy for the treatment of genetic forms of Parkinson disease. Aspen leverages proprietary AI-based genomics tools for comprehensive quality control which allows for a reduction in the time and cost of the manufacturing process required to produce a safe, reproducible, and personalized cell therapy.

The Series A funding will support the completion of all remaining IND-enabling studies and FDA submission of the IND relating to Aspen's lead product (ANPD001), as well as the recruitment and screening of a trial-ready cohort of persons with Parkinson disease and the manufacture of their cells for the lead product. Additionally, the capital will allow the company to obtain meaningful data from the Phase 1 clinical study to show evidence of biological effect of the therapy and lay the foundation for the Phase 2 multi-center randomized controlled trial. The financing will also support the continued R&D pipeline which includes autologous gene-corrected dopamine neurons for heritable forms of Parkinson disease risk (ANPD002) and programs that extend beyond dopamine neurons and explore the treatment of diseases marked by neuroinflammation.

About Aspen NeuroscienceAspen Neuroscience, Inc., is a development stage, private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson disease. Aspen's therapies are based upon the scientific work of world-renowned stem cell scientist, Dr. Jeanne Loring, who has developed a novel method for autologous neuron replacement. For more information and important updates, please visit http://www.aspenneuroscience.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/aspen-neuroscience-announces-70-million-series-a-financing-led-by-orbimed-to-advance-development-of-the-first-autologous-neuron-replacement-therapy-to-treat-parkinson-disease-301033098.html

SOURCE Aspen Neuroscience

The rest is here:
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy...

Scailyte Announces Its New Advisory Board, Composed of World Leading Clinicians and Scientists – PharmiWeb.com

SURSEE, Switzerland, March 31, 2020 (Newswire.com) - Scailyte is an ETH Zurichspin-off and Top 100 Swiss Startup applying artificial intelligence to discover novel and ultra-sensitive biomarkers from single-cell data. Over the past threeyears, it has established ScaiVision, a proprietary data analytics platform for clinical research, which enables it to achieve groundbreaking discoveries in multiple disease areas. Scailyte has validated its approach by discovering its first single-cell biomarker for the detection of skin T-cell lymphoma, which it iscurrently translating into an in vitro diagnostics application that will radically improve the diagnosis and survival chances for thousands of patients suffering from this disease. Scailyteisscaling up its efforts by applying itsbiomarker discovery approach for multiple indications in oncology and womens health. In order to strengthen Scailytes discovery potential and provide strategic guidance, ithasappointed a scientific advisory board consisting of world-leading clinicians and scientists. The scientific advisory board is being led by Scailyte's co-founder, Professor Dr. Manfred Claasen.

Scailytes mission is to provide better healthcare and transform diagnostics, with particular focus on diseases with high unmet diagnostic need. With the rise of novel single-cell technologies, we are now in the unique position to leverage the potential of high dimensional single-cell data, and Scailyte is at the forefront of turning this potential into clinical applications, says Prof. Claassen

Prof. Dr. Manfred Claassen has been recently appointed as full professor in Clinical Bioinformatics at the University Hospital of Tubingen,with a focus on machine learning for single-cell biology and precision medicine. Prof. Claassen is an alumnus of the University of Tubingen and obtained his PhD from ETH Zurich. He did postdoctoral studies at Stanford University, where he pioneered research in single-cell data analysis and subsequently started his independent research group at ETH Zurich. This activity resulted in the key developments of an algorithm that paved the way for Scailytes innovative implementation of deep learning approaches for cell identity biomarker discovery.

Prof. Dr. Emmanuella Guenova is a dermatologist, specialist in cutaneous lymphoma and laboratory diagnostics of skin diseases, and appointed professor at the Faculty of Biology and Medicine of the University of Lausanne. She is a senior physician-scientist, leading the specialized cutaneous lymphoma clinic at the Department of Dermatology of the Lausanne University Hospital (CHUV). Prof. Guenova is supporting Scailyte as a clinical advisor and principal investigator in its clinical development program for cutaneous T-cell lymphoma.

Prof. Dr. Michael Mueller is a renowned gynecologist and gynecological oncologist, and managing director of the Women's Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and womens health.

Prof. Dr. Tomas Kalina is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.

Prof. Dr. Petter Brodin is a pioneer in single-cell analysis and is advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital

Dr. Michael Stadler received training in immunology and bioinformatics from the Universities of Lausanne and Geneva. He is a scientific advisor supporting Scailytes with the development of itsdata analytics platform.After postdoctoral studies in Bern and at the Massachusetts Institute of Technology (MIT), he joined the Friedrich Miescher Institute for Biomedical Research (FMI) Basel, where he is a staff scientist and leads the computational biology group.

About Scailyte

Scailyte AG is a data-driven biomarker discovery company, founded in Luzern, Switzerland in 2017. The ETH Spin-off is using cutting edge technologies within the single-cell space and a proprietary biomarker discovery platform to develop clinical diagnostic applications in oncology and womens health. Scailyte is ranked among the Top100 Swiss Startups since 2019 and has won the MassChallenge Switzerland in 2018.

http://www.scailyte.com

Scailyte and ScaiVision are registered trademarks proprietary to Scailyte AG.

The rest is here:
Scailyte Announces Its New Advisory Board, Composed of World Leading Clinicians and Scientists - PharmiWeb.com

Overcome reproducibility challenges with live-cell assays using the power of whole-well imaging on SelectScience – SelectScience

In order to understand and interpret the intricate and dynamic processes governing cell biology and related diseases, in vitro cell-based assays are the starting point for most researchers. Many scientists opt now for adding imaging to their live-cell assay analysis in order to provide important context to results, ultimately allowing a higher level of interpretation of potential drug candidates.

However working with live cells is cumbersome and burdened with challenges, with reproducibility being a major concern. In this webinar, learn about a new plate reader with live-cell imaging and real-time cytometry that can help you can overcome factors, such as insufficient replication of experiments, poor user judgement leading to poor statistical power, and variability in reagents or techniques, that can otherwise have a critical impact on experimental outcome, as well as financial and time expense.

Plus, hear from Dr. Stefan Hasender, Senior Scientist R & D, SIRION Biotech, as he explains how the multi-parameter automated analysis capabilities of the Tecan Spark Cyto microplate reader have assisted the transduction and production of viral vector technologies through the analysis of cell confluence and counting, cell toxicity and transduction efficiency testing.

Learn how you can

Who should attend?

Students, postdocs, lab heads, group leaders, academia, CRO, biotech and biopharma, small and large pharma

Attendance certificate

All webinar participants can download a certificate of attendance, and a learning outcomes summary document for continuing education purposes.

Read more:
Overcome reproducibility challenges with live-cell assays using the power of whole-well imaging on SelectScience - SelectScience

Textbooks Still Misrepresent the Origin of Life – Discovery Institute

Editors note: The profoundest mystery and thus the deepest inspiration is life itself. Discovery Institute Press has just published a greatly expanded edition of the 1984 classic of intelligent design science literature,The Mystery of Lifes Origin. Below is an excerpt adapted from a brand new chapter. Dr. Wells, the author of the chapter, is a Senior Fellow with the Center for Science & Culture. He holds PhDs in Molecular and Cell Biology (U.C. Berkeley) and Religious Studies (Yale University).

The Miller-Urey experiment may well be called the poster child for origin-of-life research. Most modern biology students have seen some version of the drawing below, which represents an experimental apparatus used in 1952 by University of Chicago graduate student Stanley L. Miller. Because Miller performed his experiment under the supervision of Nobel laureate Harold C. Urey, and the results were published in 1953, it became known as the 1953 Miller-Urey experiment.

In 2000, I published a book titled Icons of Evolution: Why Much of What we Teach About Evolution is Wrong. I described and analyzed ten images (icons of evolution) commonly used in biology textbooks to teach high school and college students about evolutionary theory. I showed that all ten icons misrepresent the evidence and that some scientists had known this for decades.

After 2000, some textbooks were corrected, but in many cases the corrections were minor and the books continued to perpetuate the misrepresentations. This prompted me to publish another book in 2017, titled Zombie Science, which included six more icons of evolution that I didnt have room to include in my 2000 book. All sixteen icons misrepresented the evidence, but many were still being used in 2017. I called this zombie science, because although the icons were empirically dead they continued to stalk our classrooms and research institutions.

I argued that this was not due simply to laziness or a reluctance to give up an attractive theory. It revealed something much deeper: a dogmatic commitment to materialistic philosophy. Biology courses were being misused to indoctrinate students in materialism, the view that only material objects and the forces among them are real. In this view free will, spirit, intelligent design, and God are mere illusions.

One of the icons of evolution was the Miller-Urey experiment.

Read the rest inThe Mystery of Lifes Origin: The Continuing Controversy, from Discovery Institute Press.

Photo credit: In the Miller-Urey apparatus, a spark from two electrodes simulated lightning, shown above, by Griffinstorm / CC BY-SA.

See the article here:
Textbooks Still Misrepresent the Origin of Life - Discovery Institute